CELEA THERAPEUTICS
Live / Applied — Opposition pending (as of 14 Sept 2026)
What this means for you
Not registered yet, but its 09 Sept 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99382421
- Mark type
- Stylized text
- Filed
- 09 Sept 2025
- Published for opposition
- 25 Aug 2026
- Attorney of record
- CHRISTINA BROWN
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of collagen-mediated disorders; pharmaceuticals for the treatment of fibrotic-mediated disorders; pharmaceuticals for the treatment of interstitial lung diseases
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical, biotechnology, and digital medicine fields
Owner
- PureTech Health LLC, Boston, MA, US
- PureTech Health LLC, Boston, MA, US
Prosecution history
- 14 Sept 2026 — OPPOSITION INSTITUTED NO. 999999
- 14 Sept 2026 — OPPOSITION PAPERS RECEIVED AT TTAB
- 25 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Aug 2026 — PUBLISHED FOR OPPOSITION
- 19 Aug 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Jul 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 27 Jul 2026 — EXAMINER'S AMENDMENT ENTERED
- 27 Jul 2026 — EXAMINERS AMENDMENT E-MAILED
- 27 Jul 2026 — EXAMINERS AMENDMENT -WRITTEN
- 15 Feb 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 15 Feb 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 30 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 30 Jan 2026 — NON-FINAL ACTION E-MAILED
- 30 Jan 2026 — NON-FINAL ACTION WRITTEN